Historical shareholding details of T. Rowe Price Health Sciences Fund holdings in Prelude Therapeutics Inc (PRLD)

Monthly changes of T. Rowe Price Health Sciences Fund shareholding in Prelude Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 T. Rowe Price Health Sciences Fund 716,240 1.30%
Jan 31, 2025 T. Rowe Price Health Sciences Fund 716,240 1.30%
Dec 31, 2024 T. Rowe Price Health Sciences Fund 741,444 1.35%
Nov 30, 2024 T. Rowe Price Health Sciences Fund 766,237 1.39%
Oct 31, 2024 T. Rowe Price Health Sciences Fund 808,989 1.47%
Sep 30, 2024 T. Rowe Price Health Sciences Fund 809,844 1.47%
Aug 31, 2024 T. Rowe Price Health Sciences Fund 825,995 1.50%
Jun 30, 2024 T. Rowe Price Health Sciences Fund 619,654 1.13%
Mar 31, 2024 T. Rowe Price Health Sciences Fund 670,327 1.22%
Dec 31, 2023 T. Rowe Price Health Sciences Fund 771,093 1.40%
Sep 30, 2023 T. Rowe Price Health Sciences Fund 787,118 1.44%
Jun 30, 2023 T. Rowe Price Health Sciences Fund 811,342 1.48%
Mar 31, 2023 T. Rowe Price Health Sciences Fund 168,725 0.32%

View all ownership details of Prelude Therapeutics Inc